These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. U.S. National Football League athletes seeking unproven stem cell treatments. Matthews KR; Cuchiara ML Stem Cells Dev; 2014 Dec; 23 Suppl 1(Suppl 1):60-4. PubMed ID: 25457965 [TBL] [Abstract][Full Text] [Related]
6. Allowing innovative stem cell-based therapies outside of clinical trials: ethical and policy challenges. Hyun I J Law Med Ethics; 2010; 38(2):277-85. PubMed ID: 20579251 [TBL] [Abstract][Full Text] [Related]
7. Implicit hype? Representations of platelet rich plasma in the news media. Rachul C; Rasko JEJ; Caulfield T PLoS One; 2017; 12(8):e0182496. PubMed ID: 28792974 [TBL] [Abstract][Full Text] [Related]
8. Stem-cell therapy takes off in Texas. Cyranoski D Nature; 2012 Feb; 483(7387):13-4. PubMed ID: 22382952 [No Abstract] [Full Text] [Related]
9. Unproven but Profitable: The Boom in US Stem Cell Clinics. Rubin R JAMA; 2018 Oct; 320(14):1421-1423. PubMed ID: 30326510 [No Abstract] [Full Text] [Related]
10. Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders. Matthews KR; Iltis AS BMC Med Ethics; 2015 Nov; 16(1):75. PubMed ID: 26537611 [TBL] [Abstract][Full Text] [Related]
11. The US Direct-to-Consumer Marketplace for Autologous Stem Cell Interventions. Turner L Perspect Biol Med; 2018; 61(1):7-24. PubMed ID: 29805145 [TBL] [Abstract][Full Text] [Related]
12. Study: Business Booms for Unlicensed and Unproven Stem Cell Treatments. Rubin R JAMA; 2022 Feb; 327(5):414-415. PubMed ID: 35019946 [No Abstract] [Full Text] [Related]
14. Therapeutic hope, spiritual distress, and the problem of stem cell tourism. Hyun I Cell Stem Cell; 2013 May; 12(5):505-7. PubMed ID: 23642359 [TBL] [Abstract][Full Text] [Related]
15. On the Road (to a Cure?)--Stem-Cell Tourism and Lessons for Gene Editing. Charo RA N Engl J Med; 2016 Mar; 374(10):901-3. PubMed ID: 26863030 [No Abstract] [Full Text] [Related]
16. Hopes and illusions. Guest J; Anderson K Am J Bioeth; 2010 May; 10(5):47-8. PubMed ID: 20461651 [No Abstract] [Full Text] [Related]
17. FDA regulation of stem-cell-based therapies. Halme DG; Kessler DA N Engl J Med; 2006 Oct; 355(16):1730-5. PubMed ID: 17050899 [No Abstract] [Full Text] [Related]
18. International stem cell tourism and the need for effective regulation. Part II: Developing sound oversight measures and effective patient support. Cohen CB; Cohen PJ Kennedy Inst Ethics J; 2010 Sep; 20(3):207-30. PubMed ID: 21133333 [TBL] [Abstract][Full Text] [Related]
19. A RAT by Another Name: 21 Riley MF Am J Law Med; 2018 May; 44(2-3):291-308. PubMed ID: 30106653 [No Abstract] [Full Text] [Related]
20. International stem cell tourism and the need for effective regulation. Part I: Stem cell tourism in Russia and India: clinical research, innovative treatment, or unproven hype? Cohen CB; Cohen PJ Kennedy Inst Ethics J; 2010 Mar; 20(1):27-49. PubMed ID: 20506693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]